Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15005)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2016 (publication date) through Jun 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. World J Gastroenterol 2016; 22(24): 5505-5511 [PMID: 27350728 DOI: 10.3748/wjg.v22.i24.5505] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i24/5505.htm |
| Number | Citing Articles |
| 1 |
Justin J. J. van der Hooft, Robert J. Goldstone, Susan Harris, Karl E. V. Burgess, David G. E. Smith. Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of Escherichia coli. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.00252
|
| 2 |
Stefan Borgmann, Beate Rieß, David Meintrup, Ingo Klare, Guido Werner. Long-Lasting Decrease of the Acquisition of Enterococcus faecium and Gram-Negative Bacteria Producing Extended Spectrum Beta-Lactamase (ESBL) by Transient Application of Probiotics. International Journal of Environmental Research and Public Health 2020; 17(17): 6100 doi: 10.3390/ijerph17176100
|
| 3 |
Celeste Manfredi, Francesco P. Calace, Ferdinando Fusco, Carmelo Quattrone, Dario Giordano, Felice Crocetto, Massimiliano Creta, Marco De Sio, Davide Arcaniolo. Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial. World Journal of Urology 2021; 39(12): 4373 doi: 10.1007/s00345-021-03773-8
|
| 4 |
Yuanbo Pan, Junjie Cheng, Yang Zhu, Jianmin Zhang, Wenpei Fan, Xiaoyuan Chen. Immunological nanomaterials to combat cancer metastasis. Chemical Society Reviews 2024; doi: 10.1039/D2CS00968D
|
| 5 |
Timothy M. Janetos, Nancy Zakaria, Debra A. Goldstein. The Microbiome and Uveitis. The American Journal of Pathology 2023; 193(11): 1638 doi: 10.1016/j.ajpath.2023.03.004
|
| 6 |
W. Vahjen, T. Cuisiniere, J. Zentek. Protective effects of indigenous Escherichia coli against a pathogenic E. coli challenge strain in pigs. Beneficial Microbes 2017; 8(5): 779 doi: 10.3920/BM2017.0040
|
| 7 |
Soo-Young Na. Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification. The Korean Journal of Gastroenterology 2021; 77(1): 1 doi: 10.4166/kjg.2021.012
|
| 8 |
Letizia Masi, Cristina Ciuffini, Valentina Petito, Laura Francesca Pisani, Loris Riccardo Lopetuso, Cristina Graziani, Daniela Pugliese, Lucrezia Laterza, Pierluigi Puca, Federica Di Vincenzo, Marco Pizzoferrato, Daniele Napolitano, Laura Turchini, Valeria Amatucci, Elisa Schiavoni, Giuseppe Privitera, Laura Maria Minordi, Maria Chiara Mentella, Alfredo Papa, Alessandro Armuzzi, Antonio Gasbarrini, Franco Scaldaferri. Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update. Frontiers in Gastroenterology 2022; 1 doi: 10.3389/fgstr.2022.1022530
|
| 9 |
Vanessa N. DARGENIO, Stefania CASTELLANETA, Serena PANICO, Maria E. PAPAGNI, Costantino DARGENIO, Federico SCHETTINI, Ruggiero FRANCAVILLA, Fernanda CRISTOFORI. Probiotics and gastrointestinal diseases. Minerva Pediatrics 2023; 74(6) doi: 10.23736/S2724-5276.22.07031-8
|
| 10 |
Ahmed Elbermawi, Mohamed Samir Darwish, Asmaa A. El-Awady, Ahmed A. Zaki, Longxin Qiu, Reham M. Samra. Isolation and biological activities of compounds from Rumex vesicarius L. and their use as a component of a synbiotic preparation. Food Chemistry: X 2022; 14: 100306 doi: 10.1016/j.fochx.2022.100306
|
| 11 |
Himel Mallick, Siyuan Ma, Eric A. Franzosa, Tommi Vatanen, Xochitl C. Morgan, Curtis Huttenhower. Experimental design and quantitative analysis of microbial community multiomics. Genome Biology 2017; 18(1) doi: 10.1186/s13059-017-1359-z
|
| 12 |
Asmaa Mawad, Yosra A. Helmy, Abdel-Gawad Shalkami, Dipak Kathayat, Gireesh Rajashekara. E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro. Applied Microbiology and Biotechnology 2018; 102(24): 10675 doi: 10.1007/s00253-018-9417-3
|
| 13 |
Divakar Dahiya, Poonam Singh Nigam. The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer. Microorganisms 2022; 10(3): 665 doi: 10.3390/microorganisms10030665
|
| 14 |
Zhongyue Ren, Yan Hong, Yalan Huo, Lingling Peng, Huihui Lv, Jiahui Chen, Zhihua Wu, Cuixiang Wan. Prospects of Probiotic Adjuvant Drugs in Clinical Treatment. Nutrients 2022; 14(22): 4723 doi: 10.3390/nu14224723
|
| 15 |
Maja Šikić Pogačar, Dušanka Mičetić-Turk, Sabina Fijan. Probiotics in the Prevention and Management of Human Diseases. 2022; : 465 doi: 10.1016/B978-0-12-823733-5.00021-0
|
| 16 |
Rachel Golonka, Beng San Yeoh, Matam Vijay-Kumar. The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity. Journal of Innate Immunity 2019; 11(3): 249 doi: 10.1159/000494627
|
| 17 |
Matěj Hrala, Juraj Bosák, Lenka Micenková, Jitka Křenová, Matej Lexa, Viktória Pirková, Zuzana Tomáštíková, Ivana Koláčková, David Šmajs, Johanna Björkroth.
Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both
In Vitro
and
In Vivo
Conditions
. Applied and Environmental Microbiology 2021; 87(14) doi: 10.1128/AEM.03121-20
|
| 18 |
Hong-Ying Zhao, Guo-Tao Yang, Ning-Ning Sun, Yu Kong, Yun-Feng Liu. Efficacy and safety of stellate ganglion block in chronic ulcerative colitis. World Journal of Gastroenterology 2017; 23(3): 533-539 doi: 10.3748/wjg.v23.i3.533
|
| 19 |
Tetsuji Hori, Kazunori Matsuda, Kenji Oishi. Probiotics: A Dietary Factor to Modulate the Gut Microbiome, Host Immune System, and Gut–Brain Interaction. Microorganisms 2020; 8(9): 1401 doi: 10.3390/microorganisms8091401
|
| 20 |
Haojie Chen, Pengyu Lei, Hao Ji, Qinsi Yang, Bo Peng, Jiahui Ma, Yimeng Fang, Linkai Qu, Hua Li, Wei Wu, Libo Jin, Da Sun. Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio 2023; 18: 100543 doi: 10.1016/j.mtbio.2023.100543
|
| 21 |
Divakar Dahiya, Poonam Singh Nigam. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer. International Journal of Molecular Sciences 2023; 24(6): 5748 doi: 10.3390/ijms24065748
|
| 22 |
Jason R. Bush, Michelle J. Alfa. Increasing levels of Parasutterella in the gut microbiome correlate with improving low-density lipoprotein levels in healthy adults consuming resistant potato starch during a randomised trial. BMC Nutrition 2020; 6(1) doi: 10.1186/s40795-020-00398-9
|
| 23 |
Francesco Di Pierro, Alexander Bertuccioli, Mariella Saponara, Leandro Ivaldi. Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication. Minerva Gastroenterologica e Dietologica 2020; 66(2) doi: 10.23736/S1121-421X.19.02651-5
|
| 24 |
Dandan Wu, Xiaomei Li, Yanying Yu, Bingxue Gong, Xianxuan Zhou. Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917. Biotechnology Letters 2021; 43(1): 235 doi: 10.1007/s10529-020-03019-4
|
| 25 |
Ciara Kenneally, Craig P. Murphy, Roy D. Sleator, Eamonn P. Culligan. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiological Research 2022; 259: 127010 doi: 10.1016/j.micres.2022.127010
|
| 26 |
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa, Amien Ewunetie. Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212742
|
| 27 |
Ankita Srivastava, Jaya Gupta, Sunil Kumar, Awanish Kumar. Gut biofilm forming bacteria in inflammatory bowel disease. Microbial Pathogenesis 2017; 112: 5 doi: 10.1016/j.micpath.2017.09.041
|
| 28 |
Bianca JC van den Bosch, Marieke JH Coenen. Pharmacogenetics of Inflammatory Bowel Disease. Pharmacogenomics 2021; 22(1): 55 doi: 10.2217/pgs-2020-0095
|
| 29 |
Alan R. Healy, Seth B. Herzon. Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective. Journal of the American Chemical Society 2017; 139(42): 14817 doi: 10.1021/jacs.7b07807
|
| 30 |
G. Adrienne Weiss, Thierry Hennet. Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences 2017; 74(16): 2959 doi: 10.1007/s00018-017-2509-x
|
| 31 |
Pi Westi Bondegaard, Anders Meyer Torp, Priscila Guerra, Katja Ann Kristensen, Juliane Fjelrad Christfort, Karen Angeliki Krogfelt, Line Hagner Nielsen, Kinga Zor, Anja Boisen, Martin Steen Mortensen, Martin Iain Bahl, Tine Rask Licht. Delivery of E. coli Nissle to the mouse gut by mucoadhesive microcontainers does not improve its competitive ability against strains linked to ulcerative colitis. FEMS Microbiology Letters 2023; 370 doi: 10.1093/femsle/fnad110
|
| 32 |
Francesco Strati, Georgia Lattanzi, Chiara Amoroso, Federica Facciotti. Microbiota-targeted therapies in inflammation resolution. Seminars in Immunology 2022; 59: 101599 doi: 10.1016/j.smim.2022.101599
|
| 33 |
Ava Behrouzi, Hoora Mazaheri, Sarvenaz Falsafi, Zahra Hoseini Tavassol, Arfa Moshiri, Seyed Davar Siadat. Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. Journal of Diabetes & Metabolic Disorders 2020; 19(1): 597 doi: 10.1007/s40200-020-00511-6
|
| 34 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1): 7 doi: 10.1515/dmpt-2021-0150
|
| 35 |
Sanjeeva Kumar Murali, Thomas J. Mansell. Next generation probiotics: Engineering live biotherapeutics. Biotechnology Advances 2024; 72: 108336 doi: 10.1016/j.biotechadv.2024.108336
|
| 36 |
Cong Xia, Yantao Cai, Shuangyi Ren, Chenglai Xia. Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1051330
|
| 37 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1): 7 doi: 10.1515/dmpt-2021-0150
|
| 38 |
Sergio Martínez-Ruiz, Yenifer Olivo-Martínez, Cecilia Cordero, María J. Rodríguez-Lagunas, Francisco J. Pérez-Cano, Josefa Badia, Laura Baldoma. Microbiota-Derived Extracellular Vesicles as a Postbiotic Strategy to Alleviate Diarrhea and Enhance Immunity in Rotavirus-Infected Neonatal Rats. International Journal of Molecular Sciences 2024; 25(2): 1184 doi: 10.3390/ijms25021184
|
| 39 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2). Zeitschrift für Gastroenterologie 2024; 62(05): 769 doi: 10.1055/a-2271-0994
|
| 40 |
Gyu Man Oh, Won Moon, Kwang Il Seo, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park, Seun Ja Park. Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study. The Korean Journal of Gastroenterology 2021; 77(1): 12 doi: 10.4166/kjg.2020.0119
|
| 41 |
Young‐Tae Park, Taejung Kim, Jungyeob Ham, Jaeyoung Choi, Hoe‐Suk Lee, Young Joo Yeon, Soo In Choi, Nayoung Kim, Yeon‐Ran Kim, Yeong‐Jae Seok. Physiological activity of E. coli engineered to produce butyric acid. Microbial Biotechnology 2022; 15(3): 832 doi: 10.1111/1751-7915.13795
|
| 42 |
Luigi Marongiu, Heike Allgayer. Viruses in colorectal cancer. Molecular Oncology 2022; 16(7): 1423 doi: 10.1002/1878-0261.13100
|
| 43 |
Igori Balta, Eugenia Butucel, Lavinia Stef, Ioan Pet, Gratiela Gradisteanu-Pircalabioru, Carmen Chifiriuc, Ozan Gundogdu, David McCleery, Nicolae Corcionivoschi. Anti-Campylobacter Probiotics: Latest Mechanistic Insights. Foodborne Pathogens and Disease 2022; 19(10): 693 doi: 10.1089/fpd.2022.0039
|
| 44 |
Alex Steimle, Sarah Menz, Annika Bender, Brianna Ball, Alexander N. R. Weber, Thomas Hagemann, Anna Lange, Jan K. Maerz, Raphael Parusel, Lena Michaelis, Andrea Schäfer, Hans Yao, Hanna-Christine Löw, Sina Beier, Mehari Tesfazgi Mebrhatu, Kerstin Gronbach, Samuel Wagner, David Voehringer, Martin Schaller, Birgit Fehrenbacher, Ingo B. Autenrieth, Tobias A. Oelschlaeger, Julia-Stefanie Frick, Luis Teixeira. Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains. PLOS Biology 2019; 17(6): e3000334 doi: 10.1371/journal.pbio.3000334
|
| 45 |
Federica Facciotti. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases. PharmaNutrition 2022; 21: 100303 doi: 10.1016/j.phanu.2022.100303
|
| 46 |
Carina-Shianya Alvarez, Josefa Badia, Manel Bosch, Rosa Giménez, Laura Baldomà. Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01981
|
| 47 |
Carlos R Camara-Lemarroy, Luanne M Metz, V Wee Yong. Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome. World Journal of Gastroenterology 2018; 24(37): 4217-4223 doi: 10.3748/wjg.v24.i37.4217
|
| 48 |
Max van ‘t Hof, Omkar S. Mohite, Jonathan M. Monk, Tilmann Weber, Bernhard O. Palsson, Morten O. A. Sommer. High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-05108-9
|
| 49 |
Alejandro Cabezas-Cruz, José de la Fuente. Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01733
|
| 50 |
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
|
| 51 |
María-José Fábrega, Alba Rodríguez-Nogales, José Garrido-Mesa, Francesca Algieri, Josefa Badía, Rosa Giménez, Julio Gálvez, Laura Baldomà. Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01274
|
| 52 |
Peng Qiu, Takatsugu Ishimoto, Lingfeng Fu, Jun Zhang, Zhenyong Zhang, Yang Liu. The Gut Microbiota in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.733992
|
| 53 |
Victoria María Pulido, Remedios Castro, Enrique Durán-Guerrero, Cristina Lasanta, Ana Belén Díaz. Alternative beverages for probiotic foods. European Food Research and Technology 2022; 248(2): 301 doi: 10.1007/s00217-021-03904-w
|
| 54 |
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. Biomedicine & Pharmacotherapy 2023; 165: 114893 doi: 10.1016/j.biopha.2023.114893
|
| 55 |
Matthew Cheah, Reena Khanna. Pouchitis and Ileal Pouch Disorders. 2019; : 1 doi: 10.1016/B978-0-12-809402-0.00001-0
|
| 56 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición (English ed.) 2021; 68(1): 17 doi: 10.1016/j.endien.2020.01.010
|
| 57 |
Hari K. Somineni, Subra Kugathasan. The Microbiome in Patients With Inflammatory Diseases. Clinical Gastroenterology and Hepatology 2019; 17(2): 243 doi: 10.1016/j.cgh.2018.08.078
|
| 58 |
Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar. Dietary Additives and Supplements Revisited: the Fewer, the Safer for Gut and Liver Health. Current Pharmacology Reports 2019; 5(4): 303 doi: 10.1007/s40495-019-00187-4
|
| 59 |
Matteo M. Pusceddu, Josep M. Del Bas. The role of the gut microbiota in the pathophysiology of mental and neurological disorders. Psychiatric Genetics 2020; 30(4): 87 doi: 10.1097/YPG.0000000000000255
|
| 60 |
Da Hye Kim, Jihye Park, Soochan Kim, Mi Young Yoon, Hyun Woo Ma, I.Seul Park, Mijeong Son, Ji Hyung Kim, Tae Il Kim, Won Ho Kim, Sang Sun Yoon, Seung Won Kim, Jae Hee Cheon. An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways. Free Radical Biology and Medicine 2021; 174: 110 doi: 10.1016/j.freeradbiomed.2021.08.002
|
| 61 |
Ulrich Sonnenborn, Lesley Robertson. Escherichia colistrain Nissle 1917—from bench to bedside and back: history of a specialEscherichia colistrain with probiotic properties. FEMS Microbiology Letters 2016; 363(19): fnw212 doi: 10.1093/femsle/fnw212
|
| 62 |
Qian Qu, Shu-Peng Li, Qi Dong, Hong-Liang Du, Zhi-Hua Wang, Yi-Mu Ma, Xiao-Pei Gong, Yi-Qing Ding, Jing Zhou, Jia-Yan Chen, Meng-Jie Liu, Wei-Jie Lv, Shi-Ning Guo. Transcriptome profiling Revealed the potential mechanisms of Shen Lin Bai Zhu San n-butanol extract on DSS induced Colitis in Mice and LC-MS analysis. Phytomedicine 2023; 110: 154645 doi: 10.1016/j.phymed.2023.154645
|
| 63 |
Aida Mayorgas, Isabella Dotti, Azucena Salas. Microbial Metabolites, Postbiotics, and Intestinal Epithelial Function. Molecular Nutrition & Food Research 2021; 65(5) doi: 10.1002/mnfr.202000188
|
| 64 |
Leontien Depoorter, Yvan Vandenplas. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021; 13(7): 2176 doi: 10.3390/nu13072176
|
| 65 |
Jean-Philippe Nougayrède, Camille V. Chagneau, Jean-Paul Motta, Nadège Bossuet-Greif, Marcy Belloy, Frédéric Taieb, Jean-Jacques Gratadoux, Muriel Thomas, Philippe Langella, Eric Oswald, Alfredo G. Torres. A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917. mSphere 2021; 6(4) doi: 10.1128/mSphere.00624-21
|
| 66 |
Jiaojiao Yang, Dingwei Li, Mengjiao Zhang, Gaolong Lin, Sunkuan Hu, Helin Xu. From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems. Journal of Controlled Release 2023; 361: 568 doi: 10.1016/j.jconrel.2023.08.007
|
| 67 |
Withanage Prasadini Wasana, Amal Senevirathne, Chamilani Nikapitiya, Tae-Yang Eom, Youngdeuk Lee, Jong-Soo Lee, Do-Hyung Kang, Chulhong Oh, Mahanama De Zoysa. A Novel Pseudoalteromonas xiamenensis Marine Isolate as a Potential Probiotic: Anti-Inflammatory and Innate Immune Modulatory Effects against Thermal and Pathogenic Stresses. Marine Drugs 2021; 19(12): 707 doi: 10.3390/md19120707
|
| 68 |
Mukta Gupta, Vijay Mishra, Monica Gulati, Bhupinder Kapoor, Amrinder Kaur, Reena Gupta, Murtaza M. Tambuwala. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology 2022; 30(2): 397 doi: 10.1007/s10787-022-00931-1
|
| 69 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición 2021; 68(1): 17 doi: 10.1016/j.endinu.2020.01.004
|
| 70 |
Manon Oliero, Roy Hajjar, Thibault Cuisiniere, Gabriela Fragoso, Annie Calvé, Manuela M. Santos. Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1067505
|
| 71 |
Jun Jie Wong, Foo Kiong Ho, Pei Yi Choo, Kelvin K. L. Chong, Chee Meng Benjamin Ho, Ramesh Neelakandan, Damien Keogh, Timothy Barkham, John Chen, Chuan Fa Liu, Kimberly A. Kline, Andreas Peschel. Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competition. PLOS Pathogens 2022; 18(9): e1010766 doi: 10.1371/journal.ppat.1010766
|
| 72 |
Benedetta Parodi, Nicole Kerlero de Rosbo. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.718220
|
| 73 |
Jiwei Li, Mengchi Sun, Linlin Liu, Weiguang Yang, Ao Sun, Jicheng Yu, Dongchun Liu, Wutong Zhao, Maosheng Cheng, Zhonggui He, Zhen Gu, Jin Sun. Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis. Nano Letters 2023; 23(18): 8593 doi: 10.1021/acs.nanolett.3c02408
|
| 74 |
Pichet Praveschotinunt, Anna M. Duraj-Thatte, Ilia Gelfat, Franziska Bahl, David B. Chou, Neel S. Joshi. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-13336-6
|
| 75 |
Jamison P. Huddleston, James B. Thoden, Brandon J. Dopkins, Tamari Narindoshvili, Blair J. Fose, Hazel M. Holden, Frank M. Raushel. Structural and Functional Characterization of YdjI, an Aldolase of Unknown Specificity in Escherichia coli K12. Biochemistry 2019; 58(31): 3340 doi: 10.1021/acs.biochem.9b00326
|
| 76 |
Markus F. Neurath. Current and emerging therapeutic targets for IBD. Nature Reviews Gastroenterology & Hepatology 2017; 14(5): 269 doi: 10.1038/nrgastro.2016.208
|
| 77 |
Rudolf von Bünau, Andreas Erhardt, Eduard Stange. Comment on Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021, 13, 2176. Nutrients 2022; 14(4): 724 doi: 10.3390/nu14040724
|
| 78 |
Leontien Depoorter, Yvan Vandenplas. Probiotics. 2022; : 425 doi: 10.1016/B978-0-323-85170-1.00014-2
|
| 79 |
Shuang Li, Yi-Xuan Zhang. Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Critical Reviews in Microbiology 2024; 50(3): 371 doi: 10.1080/1040841X.2023.2202237
|
| 80 |
Stefano Guandalini, Naire Sansotta. Probiotics and Child Gastrointestinal Health. Advances in Experimental Medicine and Biology 2019; 1125: 101 doi: 10.1007/5584_2018_319
|
| 81 |
Alejandro Cabezas-Cruz, Thomas Pollet, Agustín Estrada-Peña, Eleonore Allain, Sarah I. Bonnet, Sara Moutailler. Ticks and Tick-Borne Pathogens. 2019; doi: 10.5772/intechopen.80511
|
| 82 |
Lea Gnatzy, George Ismailos, Maria Vertzoni, Christos Reppas. Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities. European Journal of Pharmaceutical Sciences 2023; 188: 106510 doi: 10.1016/j.ejps.2023.106510
|
| 83 |
Abhinav Sharma, Vishnu Raman, Jungwoo Lee, Neil S. Forbes. Microbial Imbalance Induces Inflammation by Promoting Salmonella Penetration through the Mucosal Barrier. ACS Infectious Diseases 2022; 8(5): 969 doi: 10.1021/acsinfecdis.1c00530
|
| 84 |
Ling Zhao, Mingxin Zhao, Xiankun Wang, Chenxi Jia. Proteomic Analysis of Caco-2 Cells Disrupted by EcN 1917-Derived OMVs Reveals Molecular Information on Bacteria-Mediated Cancer Cell Migration. Journal of Proteome Research 2024; doi: 10.1021/acs.jproteome.4c00176
|
| 85 |
Yenifer Olivo-Martínez, Sergio Martínez-Ruiz, Cecilia Cordero-Alday, Manel Bosch, Josefa Badia, Laura Baldoma. Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 in the Interleukin-1β-Induced Inflammation Model of Intestinal Epithelial Cells. International Journal of Molecular Sciences 2024; 25(10): 5338 doi: 10.3390/ijms25105338
|
| 86 |
Jiayu Ye, Lauren A. E. Erland, Sandeep K. Gill, Stephanie L. Bishop, Andrea Verdugo-Meza, Susan J. Murch, Deanna L. Gibson. Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products. Biomolecules 2021; 11(5): 738 doi: 10.3390/biom11050738
|
| 87 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009. Zeitschrift für Gastroenterologie 2023; 61(08): 1046 doi: 10.1055/a-2060-0935
|
| 88 |
Torsten Kucharzik, Axel U. Dignass, Raja Atreya, Bernd Bokemeyer, Philip Esters, Klaus Herrlinger, Klaus Kannengießer, Peter Kienle, Jost Langhorst, Andreas Lügering, Stefan Schreiber, Andreas Stallmach, Jürgen Stein, Andreas Sturm, Niels Teich, Britta Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Zeitschrift für Gastroenterologie 2020; 58(12): e241 doi: 10.1055/a-1296-3444
|
| 89 |
Hussein Sabit, Areej Kassab, Donia Alaa, Shaza Mohamed, Shaimaa Abdel-Ghany, Mohamed Mansy, Osama A. Said, Mona A. Khalifa, Halah Hafiz, Asmaa M. Abushady. The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients. Current Issues in Molecular Biology 2023; 45(5): 4080 doi: 10.3390/cimb45050260
|
| 90 |
M. Tyler Nelson, Mark R. Charbonneau, Heidi G. Coia, Mary J. Castillo, Corey Holt, Eric S. Greenwood, Peter J. Robinson, Elaine A. Merrill, David Lubkowicz, Camilla A. Mauzy. Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-23072-5
|
| 91 |
Jun Shi, DongXue Ma, ShanHu Gao, Fei Long, Xin Wang, XingYu Pu, Richard D. Cannon, Ting-Li Han. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1219763
|
| 92 |
Husheem Michael, Ayako Miyazaki, Stephanie N. Langel, Joshua O. Amimo, Maryssa K. Kick, Juliet Chepngeno, Francine C. Paim, David D. Fischer, Gireesh Rajashekara, Linda J. Saif, Anastasia N. Vlasova. Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model. Vaccines 2022; 10(1): 83 doi: 10.3390/vaccines10010083
|
| 93 |
Marco Constante, Gabriela Fragoso, Joseph Lupien-Meilleur, Annie Calvé, Manuela M. Santos. Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis. Inflammatory Bowel Diseases 2017; 23(5): 753 doi: 10.1097/MIB.0000000000001089
|
| 94 |
Guigen Teng, Zilin Liu, Yun Liu, Ting Wu, Yun Dai, Huahong Wang, Weihong Wang. Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.819336
|
| 95 |
Otakar Dusek, Alena Fajstova, Aneta Klimova, Petra Svozilkova, Tomas Hrncir, Miloslav Kverka, Stepan Coufal, Johan Slemin, Helena Tlaskalova-Hogenova, John V. Forrester, Jarmila Heissigerova. Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917. Cells 2020; 10(1): 23 doi: 10.3390/cells10010023
|
| 96 |
Manyu Liang, Jing Zhang, Yanhong Yang, Yi Xia, Lintao Liu, Li Liu, Qin Wang, Xiaowei Gao. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice. World Journal of Microbiology and Biotechnology 2023; 39(1) doi: 10.1007/s11274-022-03452-9
|
| 97 |
Kangsan Kim, Donghui Choe, Minjeong Kang, Bong Hyun Sung, Haseong Kim, Seung‐Goo Lee, Dae‐Hee Lee, Byung‐Kwan Cho. Principles in Microbiome Engineering. 2022; : 93 doi: 10.1002/9783527825462.ch3
|
| 98 |
Manonmani Soundararajan, Rudolf von Bünau, Tobias A. Oelschlaeger. K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic E. coli Strain Nissle 1917. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02783
|
| 99 |
Atchareeya Nakkarach, Hooi Ling Foo, Adelene Ai-Lian Song, Sunee Nitisinprasert, Ulaiwan Withayagiat. Promising discovery of beneficial Escherichia coli in the human gut. 3 Biotech 2020; 10(7) doi: 10.1007/s13205-020-02289-z
|
| 100 |
Fernanda Cristofori, Vanessa Nadia Dargenio, Costantino Dargenio, Vito Leonardo Miniello, Michele Barone, Ruggiero Francavilla. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.578386
|
| 101 |
Louis C Dacquay, Derek Tsang, Donny Chan, John Parkinson, Dana J Philpott, David R McMillen. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1994832
|
| 102 |
Jiali Yang, Guizhen Zhang, Xinyuan Yang, Mengyun Peng, Shengchan Ge, Shaochong Tan, Zhiyang Wen, Yifei Wang, Sixuan Wu, Yan Liang, Jingyi An, Kaixiang Zhang, Junjie Liu, Jinjin Shi, Zhenzhong Zhang. An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment. Chemical Engineering Journal 2022; 446: 137204 doi: 10.1016/j.cej.2022.137204
|
| 103 |
Liang Dai, Yingjue Tang, Wenjun Zhou, Yanqi Dang, Qiaoli Sun, Zhipeng Tang, Mingzhe Zhu, Guang Ji. Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.620724
|
| 104 |
Yu. O. Shulpekova, V. Yu. Rusyaev. Daily probiotics: benefits and reasonable application. Meditsinskiy sovet = Medical Council 2021; (15): 136 doi: 10.21518/2079-701X-2021-15-136-143
|
| 105 |
Piu Saha, Beng San Yeoh, Rodrigo A. Olvera, Xia Xiao, Vishal Singh, Deepika Awasthi, Bhagawat C. Subramanian, Qiuyan Chen, Madhu Dikshit, Yanming Wang, Carole A. Parent, Matam Vijay-Kumar. Bacterial Siderophores Hijack Neutrophil Functions. The Journal of Immunology 2017; 198(11): 4293 doi: 10.4049/jimmunol.1700261
|
| 106 |
Sheng Liu, Wenjing Zhao, Ping Lan, Xiangyu Mou. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein & Cell 2021; 12(5): 331 doi: 10.1007/s13238-020-00745-3
|
| 107 |
Christian Zimmermann, Marius Schild, Clemens Kunz, Kurt Zimmermann, Sabine Kuntz. Effects of live and heat-inactivated E. coli strains and their supernatants on immune regulation in HT-29 cells. European Journal of Microbiology and Immunology 2018; 8(2): 41 doi: 10.1556/1886.2018.00004
|
| 108 |
Bothyna Ghanem, Randa Nayef Haddadin. Multiple drug resistance and biocide resistance in Escherichia coli environmental isolates from hospital and household settings. Antimicrobial Resistance & Infection Control 2018; 7(1) doi: 10.1186/s13756-018-0339-8
|
| 109 |
Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon. Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model. Intestinal Research 2021; 19(4): 478 doi: 10.5217/ir.2021.00121
|
| 110 |
Caterina Foppa, Tommy Rizkala, Alessandro Repici, Cesare Hassan, Antonino Spinelli. Microbiota and IBD: Current knowledge and future perspectives. Digestive and Liver Disease 2024; 56(6): 911 doi: 10.1016/j.dld.2023.11.015
|
| 111 |
Jun-Hwan Yoo, Mark Donowitz. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases. World Journal of Gastroenterology 2019; 25(30): 4125-4147 doi: 10.3748/wjg.v25.i30.4125
|
| 112 |
Rasmita Mishra, Smrutishree Mohanty, Soumendu Mahapatra, Punit Prasad. Microbiome Therapeutics. 2023; : 289 doi: 10.1016/B978-0-323-99336-4.00008-2
|
| 113 |
Ruth Dudek-Wicher, Adam Junka, Justyna Paleczny, Marzenna Bartoszewicz. Clinical Trials of Probiotic Strains in Selected Disease Entities. International Journal of Microbiology 2020; 2020: 1 doi: 10.1155/2020/8854119
|
| 114 |
Junhua Xie, Qiqiong Li, Shaoping Nie. Bacterial extracellular vesicles: An emerging postbiotic. Trends in Food Science & Technology 2024; 143: 104275 doi: 10.1016/j.tifs.2023.104275
|
| 115 |
Kaisa Hiippala, Hanne Jouhten, Aki Ronkainen, Anna Hartikainen, Veera Kainulainen, Jonna Jalanka, Reetta Satokari. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018; 10(8): 988 doi: 10.3390/nu10080988
|
| 116 |
Mingyang Hu, Xiyun Zhang, Jinze Li, Luotong Chen, Xiaolin He, Tingting Sui. Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.940196
|
| 117 |
Naga Sandhya Guntaka, Alan R. Healy, Jason M. Crawford, Seth B. Herzon, Steven D. Bruner. Structure and Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway. ACS Chemical Biology 2017; 12(10): 2598 doi: 10.1021/acschembio.7b00479
|
| 118 |
Yong-Hua Shen, Hao Zhu, Lin Zhou, Yan-Qing Zheng, Zhan Zhang, Ying Xie, Zhen-Qing Liu, Chun-Yan Peng, Lei Wang, Cheng Zhao, Xiao-Qi Zhang. In inflammatory bowel disease and extraintestinal manifestations: What role does microbiome play?. Engineered Regeneration 2023; 4(4): 337 doi: 10.1016/j.engreg.2023.04.005
|
| 119 |
Alan R. Healy, Herman Nikolayevskiy, Jaymin R. Patel, Jason M. Crawford, Seth B. Herzon. A Mechanistic Model for Colibactin-Induced Genotoxicity. Journal of the American Chemical Society 2016; 138(48): 15563 doi: 10.1021/jacs.6b10354
|
| 120 |
Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020; 9(5): 1234 doi: 10.3390/cells9051234
|
| 121 |
Oliver Grundmann. Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel Disorders. EMJ Microbiology & Infectious Diseases 2020; : 42 doi: 10.33590/emjmicrobiolinfectdis/20-00050
|
| 122 |
Nathan Crook, Aura Ferreiro, Andrew J. Gasparrini, Mitchell W. Pesesky, Molly K. Gibson, Bin Wang, Xiaoqing Sun, Zevin Condiotte, Stephen Dobrowolski, Daniel Peterson, Gautam Dantas. Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut. Cell Host & Microbe 2019; 25(4): 499 doi: 10.1016/j.chom.2019.02.005
|
| 123 |
Seockmo Ku, Suyoung Yang, Hyun Ha Lee, Deokyeong Choe, Tony V. Johnston, Geun Eog Ji, Myeong Soo Park. Biosafety assessment of Bifidobacterium animalis subsp. lactis AD011 used for human consumption as a probiotic microorganism. Food Control 2020; 117: 106985 doi: 10.1016/j.foodcont.2019.106985
|
| 124 |
Jie Gao, Xiyu Li, Guohua Zhang, Faizan Ahmed Sadiq, Jesus Simal‐Gandara, Jianbo Xiao, Yaxin Sang. Probiotics in the dairy industry—Advances and opportunities. Comprehensive Reviews in Food Science and Food Safety 2021; 20(4): 3937 doi: 10.1111/1541-4337.12755
|
| 125 |
Xing Jin, Sungjun An, Weston Kightlinger, Jiacheng Zhou, Seok Hoon Hong. Engineering Escherichia coli to produce and secrete colicins for rapid and selective biofilm cell killing. AIChE Journal 2021; 67(12) doi: 10.1002/aic.17466
|
| 126 |
Zachary J. S. Mays, Todd C. Chappell, Nikhil U. Nair. Quantifying and Engineering Mucus Adhesion of Probiotics. ACS Synthetic Biology 2020; 9(2): 356 doi: 10.1021/acssynbio.9b00356
|
| 127 |
Yvan Vandenplas, Leontien Depoorter. Reply to von Bünau et al. Comment on “Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021, 13, 2176”. Nutrients 2022; 14(4): 725 doi: 10.3390/nu14040725
|
| 128 |
Gopal S Palandurkar, Sunil Kumar. Biofilm's Impact on Inflammatory Bowel Diseases . Cureus 2023; doi: 10.7759/cureus.45510
|